Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma

Figure 1

Predicted probability of disease progression according to fold-increase in plasma NT-pro-BNP after two weeks of sunitinib treatment. The effect of increase is statistically significant (p-value = 0.0274) but the 95% confidence limits of predicted probability are wide due to the small size of the sample (shaded area).

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us